What Does BCAT-IN-4 Mean?
The key conclusion level was the protection and tolerability of sifalimumab. Therapy-emergent adverse events (AEs) and serious AEs (SAEs) as well as their severity, end result, and any partnership for the review medication have been recorded by the investigator throughout the research. AEs have been deemed likely to be connected to review medicatio